Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa Academic Article uri icon


MeSH Major

  • Antibodies, Monoclonal
  • Aspirin
  • Heparin
  • Immunoglobulin Fab Fragments
  • Platelet Adhesiveness
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors


  • In contrast to aspirin or heparin, the in vivo injection of c7E3 Fab considerably reduces platelet aggregate formation mediated by the binding of fibrinogen, vWF, or some other ligand to platelet GPIIb-IIIa under conditions of abnormally increased shear stress analogous to those in narrowed coronary arteries. Platelet adherence to collagen I/vWF is not affected. This study describes an in vitro model of arterial injury (similar to angioplasty) that uses human blood to compare directly, in real time, the precise relative effects of aspirin, heparin, and c7E3 Fab on platelet adhesion and subsequent aggregation.

publication date

  • January 1995



  • Academic Article



  • eng

PubMed ID

  • 7867173

Additional Document Info

start page

  • 1354

end page

  • 62


  • 91


  • 5